AZN.L

AstraZeneca PLC LSE · AZN.L

$12,702.00 +210.00 (+1.68%)

Pullback · -0.60σ

+ Compare Open in Sniper

Mkt cap $197.0B

P/E 25.7

Day $12504.00 – $12778.00

52wk $9892.00 – $15732.00

Avg vol 2.3M

Beta 0.23

Div yld 1.89%

Next earnings 2026-07-27

Quick read

At a glance

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN.L last traded at $12,702, up 1.7% on the day; that's in the middle part of its 52-week range ($9,892–$15,732). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

The next scheduled earnings report (2026-07-27) is the biggest known catalyst on the calendar, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

Price is sitting close to its normal range — not meaningfully overheated yet.

Long —

Setup score 15 / 100

Price is sitting close to its normal range — no real dip to buy yet.

· RSI hook from oversold (41)
· Stochastic bull cross
· Counter-trend long in breakout down

Technical read: above KC1 lower, -0.61 ATR from EMA21 · no notable pattern

What it means: Price is sitting close to its normal range — no real dip to buy yet. The trigger bar shows no standout candle signal yet.

Score split: chart signals 15 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 15 pts

Cycle position 6

Momentum 9

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

Setup score 16 / 100

Price is sitting close to its normal range — not meaningfully overheated yet.

· Aligned with breakout down (strong tailwind)

Technical read: below KC1 upper, -0.61 ATR from EMA21 · no notable pattern

What it means: Price is sitting close to its normal range — not meaningfully overheated yet. The trigger bar shows no standout candle signal yet.

Score split: chart signals 16 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 16 pts

Cycle position 6

Market fit 10

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Key statistics

All statistics →

AZN.L is a $197.0 billion company, priced at 26× last year's earnings, and it moves more calmly than the market (beta 0.2).

Market cap $197.0B

P/E ttm 25.7

Beta 0.23

52w range $9892.00 – $15732.00

Avg volume 2.3M

Dividend yield 1.89%

Sector Healthcare

Next earnings 2026-07-27

52-week range · today's price

$9892.00$15732.00

More on AZN.L

Earnings

See more →

Last reported: 2026-04-29
EPS (act / est): 2.58 / 2.52
Surprise: +2.4%
Next report: 2026-07-27

About

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Ple…